DHRS12 – Targeting the ubiquitin–proteasome system for cancer therapy

inhibitors have already been associated with liver organ toxicity, but several

November 3, 2018 by Katherine Lewis Leave a Comment

inhibitors have already been associated with liver organ toxicity, but several instances have already been reported in individuals receiving therapy for rheumatologic disease. reactivation of hepatitis B, demyelinating neurologic disease, and congestive center failure, among additional undesireable effects [3]. Instances of DHRS12 TNF-antagonist-induced liver organ toxicity have already been reported, but primarily in individuals getting … [Read more…]

Background and Purpose Age-related changes in the cerebrovasculature, including blood-brain barrier

February 9, 2018 by Katherine Lewis Leave a Comment

Background and Purpose Age-related changes in the cerebrovasculature, including blood-brain barrier (BBB) disruption, are emerging as potential risks for diverse neurological conditions. proteins in the cortical microvessels were reduced in BubR1H/H mice, consistent with a compromised BBB honesty from permeability assays. Importantly, the protection of microvessels by end-feet of aquaporin 4 (AQP4)-immunoreactive astrocytes was not … [Read more…]